Delivery Order SPE2DR25D2014-SPE2DR26FZ65A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,153.54. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 10, 2025, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $10,058.42 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $5,044.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.20 for Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems. This delivery...
- The Defense Logistics Agency (DLA) awarded a $5,783.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill the order from its corporate office location. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a delivery order valued at $3,587.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,015.06 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion deadline of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,814.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ65ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.99 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication widely used in military and veteran healthcare systems, reflecting the pharmaceutical distributor's role in supporting federal medical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As the prime contractor on this IDC, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates its capability to serve critical customers including the Defense Health Agency and U.S. Coast Guard through flexible and competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/6/25 |